wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50079741-BC84D661-195A-456D-8247-37C652CA4B96
Q50079741-BC84D661-195A-456D-8247-37C652CA4B96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50079741-BC84D661-195A-456D-8247-37C652CA4B96
A review article on biosimilar infliximab SB2 in the treatment of rheumatoid arthritis.
P2860
Q50079741-BC84D661-195A-456D-8247-37C652CA4B96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50079741-BC84D661-195A-456D-8247-37C652CA4B96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bded5efed56942334d9179976d20b933fe5a65df
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.